|
1
|
Choi D, Lee HW, Hur KY, Kim JJ, Park GS,
Jang SH, Song YS, Jang KS and Paik SS: Cancer stem cell markers
CD133 and CD24 correlate with invasiveness and differentiation in
colorectal adenocarcinoma. World J Gastroenterol. 15:2258–2264.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Su YJ, Lai HM, Chang YW, Chen GY and Lee
JL: Direct reprogramming of stem cell properties in colon cancer
cells by CD44. EMBO J. 30:3186–3199. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ke J, Wu X, Wu X, He X, Lian L, Zou Y, He
X, Wang H, Luo Y, Wang L, et al: A subpopulation of
CD24+ cells in colon cancer cell lines possess stem cell
characteristics. Neoplasma. 59:282–288. 2012. View Article : Google Scholar
|
|
4
|
Chen Y, Yu D, Zhang H, He H, Zhang C, Zhao
W and Shao RG: CD133+EpCAM+ phenotype
possesses more characteristics of tumor initiating cells in
hepatocellular carcinoma Huh7 cells. Int J Biol Sci. 8:992–1004.
2012. View Article : Google Scholar :
|
|
5
|
Barker N, Huch M, Kujala P, van de
Wetering M, Snippert HJ, van Es JH, Sato T, Stange DE, Begthel H,
van den Born M, et al: Lgr5+ve stem cells drive
self-renewal in the stomach and build long-lived gastric units in
vitro. Cell Stem Cell. 6:25–36. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Levin TG, Powell AE, Davies PS, Silk AD,
Dismuke AD, Anderson EC, Swain JR and Wong MH: Characterization of
the intestinal cancer stem cell marker CD166 in the human and mouse
gastrointestinal tract. Gastroenterology. 139:2072–2082. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Haraguchi N, Ohkuma M, Sakashita H,
Matsuzaki S, Tanaka F, Mimori K, Kamohara Y, Inoue H and Mori M:
CD133+CD44+ population efficiently enriches
colon cancer initiating cells. Ann Surg Oncol. 15:2927–2933. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hou NY, Yang K, Chen T, Chen XZ, Zhang B,
Mo XM and Hu JK: CD133+CD44+ subgroups may be
human small intestinal stem cells. Mol Biol Rep. 38:997–1004. 2011.
View Article : Google Scholar
|
|
9
|
Liao KL, Bai XF and Friedman A: The role
of CD200-CD200R in tumor immune evasion. J Theor Biol. 328:65–76.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Coles SJ, Hills RK, Wang EC, Burnett AK,
Man S, Darley RL and Tonks A: Expression of CD200 on AML blasts
directly suppresses memory T-cell function. Leukemia. 26:2148–2151.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Coles SJ, Wang EC, Man S, Hills RK,
Burnett AK, Tonks A and Darley RL: CD200 expression suppresses
natural killer cell function and directly inhibits patient
anti-tumor response in acute myeloid leukemia. Leukemia.
25:792–799. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Costello DA, Lyons A, Denieffe S, Browne
TC, Cox FF and Lynch MA: Long term potentiation is impaired in
membrane glycoprotein CD200-deficient mice: A role for Toll-like
receptor activation. J Biol Chem. 286:34722–34732. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moreaux J, Veyrune JL, Reme T, De Vos J
and Klein B: CD200: A putative therapeutic target in cancer.
Biochem Biophys Res Commun. 366:117–122. 2008. View Article : Google Scholar
|
|
14
|
Kretz-Rommel A, Qin F, Dakappagari N,
Ravey EP, McWhirter J, Oltean D, Frederickson S, Maruyama T, Wild
MA, Nolan MJ, et al: CD200 expression on tumor cells suppresses
antitumor immunity: New approaches to cancer immunotherapy. J
Immunol. 178:5595–5605. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Talebian F and Bai XF: The role of tumor
expression of CD200 in tumor formation, metastasis and
susceptibility to T lymphocyte adoptive transfer therapy.
OncoImmunology. 1:971–973. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kawasaki BT, Mistree T, Hurt EM, Kalathur
M and Farrar WL: Co-expression of the toleragenic glycoprotein,
CD200, with markers for cancer stem cells. Biochem Biophys Res
Commun. 364:778–782. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang X, Li M, Wang J, Yeung CM, Zhang H,
Kung HF, Jiang B and Lin MC: The BH3-only protein, PUMA, is
involved in oxaliplatin-induced apoptosis in colon cancer cells.
Biochem Pharmacol. 71:1540–1550. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li YF, Xiao B, Lai ZS, Tu SF, Wang YY and
Zhang XL: Spheres isolated from Colo205 cell line possess cancer
stem-like cells under serum-free culture condition. Nan Fang Yi Ke
Da Xue Xue Bao. 28:236–240. 2008.In Chinese. PubMed/NCBI
|
|
19
|
Alexaki VI, Javelaud D, Van Kempen LC,
Mohammad KS, Dennler S, Luciani F, Hoek KS, Juàrez P, Goydos JS,
Fournier PJ, et al: GLI2-mediated melanoma invasion and metastasis.
J Natl Cancer Inst. 102:1148–1159. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gest C, Joimel U, Huang L, Pritchard LL,
Petit A, Dulong C, Buquet C, Hu CQ, Mirshahi P, Laurent M, et al:
Rac3 induces a molecular pathway triggering breast cancer cell
aggressiveness: Differences in MDA-MB-231 and MCF-7 breast cancer
cell lines. BMC Cancer. 13:632013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Spindler KL, Lindebjerg J, Lahn M,
Kjaer-Frifeldt S and Jakobsen A: Protein kinase C-beta II (PKC-beta
II) expression in patients with colorectal cancer. Int J Colorectal
Dis. 24:641–645. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sakai J: Activation of 'fat burning
sensor' peroxisome proliferator-activated receptor delta induces
fatty acid beta-oxidation in skeletal muscle and attenuates
metabolic syndrome. Seikagaku. 76:517–524. 2004.In Japanese.
PubMed/NCBI
|
|
23
|
Peters JM, Lee SS, Li W, Ward JM,
Gavrilova O, Everett C, Reitman ML, Hudson LD and Gonzalez FJ:
Growth, adipose, brain, and skin alterations resulting from
targeted disruption of the mouse peroxisome proliferator-activated
receptor beta (delta). Mol Cell Biol. 20:5119–5128. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang C, Ting AT and Seed B: PPAR-gamma
agonists inhibit production of monocyte inflammatory cytokines.
Nature. 391:82–86. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li HJ, Wang CY, Mi Y, Du CG, Cao GF, Sun
XC, Liu DJ and Shorgan B: FasL-induced apoptosis in bovine oocytes
via the Bax signal. Theriogenology. 80:248–255. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ohkubo T and Yamazaki J: T-type
voltage-activated calcium channel Cav3.1, but not
Cav3.2, is involved in the inhibition of proliferation
and apoptosis in MCF-7 human breast cancer cells. Int J Oncol.
41:267–275. 2012.PubMed/NCBI
|
|
27
|
Toyota M, Ho C, Ohe-Toyota M, Baylin SB
and Issa JP: Inactivation of CACNA1G, a T-type calcium channel
gene, by aberrant methylation of its 5′ CpG island in human tumors.
Cancer Res. 59:4535–4541. 1999.PubMed/NCBI
|
|
28
|
López-Vicente L, Armengol G, Pons B, Coch
L, Argelaguet E, Lleonart M, Hernández-Losa J, de Torres I and
Ramon y Cajal S: Regulation of replicative and stress-induced
senescence by RSK4, which is down-regulated in human tumors. Clin
Cancer Res. 15:4546–4553. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lévy P, Robin H, Bertrand F, Kornprobst M
and Capeau J: Butyrate-treated colonic Caco-2 cells exhibit
defective integrin-mediated signaling together with increased
apoptosis and differentiation. J Cell Physiol. 197:336–347. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Turecková J, Vojtechová M, Kucerová D,
Velek J and Tuhácková Z: Sodium butyrate-mediated differentiation
of colorectal cancer cells: Regulation of PKCβII by PI 3-kinase.
Int J Mol Med. 15:329–335. 2005.
|
|
31
|
Cullen SP, Henry CM, Kearney CJ, Logue SE,
Feoktistova M, Tynan GA, Lavelle EC, Leverkus M and Martin SJ:
Fas/CD95-induced chemokines can serve as 'find-me' signals for
apoptotic cells. Mol Cell. 49:1034–1048. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Walker PR, Saas P and Dietrich PY: Role of
Fas ligand (CD95L) in immune escape: The tumor cell strikes back. J
Immunol. 158:4521–4524. 1997.PubMed/NCBI
|
|
33
|
O'Connell J, O'Sullivan GC, Collins JK and
Shanahan F: The Fas counterattack: Fas-mediated T cell killing by
colon cancer cells expressing Fas ligand. J Exp Med. 184:1075–1082.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bernstorff WV, Glickman JN, Odze RD,
Farraye FA, Joo HG, Goedegebuure PS and Eberlein TJ: Fas
(CD95/APO-1) and Fas ligand expression in normal pancreas and
pancreatic tumors. Implications for immune privilege and immune
escape. Cancer. 94:2552–2560. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gryko M, Guzińska-Ustymowicz K, Pryczynicz
A, Cepowicz D, Kukliński A, Czyżewska J, Kemona A and Kędra B:
Correlation between Fas and FasL proteins expression in normal
gastric mucosa and gastric cancer. Folia Histochem Cytobiol.
49:142–147. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang W, Zheng Z, Yu W, Lin H, Cui B and
Cao F: Polymorphisms of the FAS and FASL genes and risk of breast
cancer. Oncol Lett. 3:625–628. 2012.PubMed/NCBI
|
|
37
|
Hoogwater FJ, Steller EJ, Westendorp BF,
Borel Rinkes IH and Kranenburg O: CD95 signaling in colorectal
cancer. Biochim Biophys Acta. 1826:189–198. 2012.PubMed/NCBI
|
|
38
|
Wu HT, Chen W, Cheng KC, Ku PM, Yeh CH and
Cheng JT: Oleic acid activates peroxisome proliferator-activated
receptor δ to compensate insulin resistance in steatotic cells. J
Nutr Biochem. 23:1264–1270. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fan Y, Wang Y, Tang Z, Zhang H, Qin X, Zhu
Y, Guan Y, Wang X, Staels B, Chien S, et al: Suppression of
pro-inflammatory adhesion molecules by PPAR-delta in human vascular
endothelial cells. Arterioscler Thromb Vasc Biol. 28:315–321. 2008.
View Article : Google Scholar
|
|
40
|
Cohen G, Riahi Y, Shamni O, Guichardant M,
Chatgilialoglu C, Ferreri C, Kaiser N and Sasson S: Role of lipid
peroxidation and PPAR-δ in amplifying glucose-stimulated insulin
secretion. Diabetes. 60:2830–2842. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mansure JJ, Nassim R and Kassouf W:
Peroxisome proliferator-activated receptor gamma in bladder cancer:
A promising therapeutic target. Cancer Biol Ther. 8:6–15. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tsukahara T, Hanazawa S, Kobayashi T,
Iwamoto Y and Murakami-Murofushi K: Cyclic phosphatidic acid
decreases proliferation and survival of colon cancer cells by
inhibiting peroxisome proliferator-activated receptor γ.
Prostaglandins Other Lipid Mediat. 93:126–133. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gupta RA, Wang D, Katkuri S, Wang H, Dey
SK and DuBois RN: Activation of nuclear hormone receptor peroxisome
proliferator-activated receptor-delta accelerates intestinal
adenoma growth. Nat Med. 10:245–247. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Genini D, Garcia-Escudero R, Carbone GM
and Catapano CV: Transcriptional and non-transcriptional functions
of PPARβ/δ in non-small cell lung cancer. PLoS One. 7:e460092012.
View Article : Google Scholar
|
|
45
|
Morales-Garcia JA, Luna-Medina R,
Alfaro-Cervello C, Cortes-Canteli M, Santos A, Garcia-Verdugo JM
and Perez-Castillo A: Peroxisome proliferator-activated receptor γ
ligands regulate neural stem cell proliferation and differentiation
in vitro and in vivo. Glia. 59:293–307. 2011. View Article : Google Scholar
|
|
46
|
Giles RH, van Es JH and Clevers H: Caught
up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta.
1653:1–24. 2003.PubMed/NCBI
|
|
47
|
Buttler K, Becker J, Pukrop T and Wilting
J: Maldevelopment of dermal lymphatics in Wnt5a-knockout-mice. Dev
Biol. 381:365–376. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gattinoni L, Zhong XS, Palmer DC, Ji Y,
Hinrichs CS, Yu Z, Wrzesinski C, Boni A, Cassard L, Garvin LM, et
al: Wnt signaling arrests effector T cell differentiation and
generates CD8+ memory stem cells. Nat Med. 15:808–813.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yaguchi T, Goto Y, Kido K, Mochimaru H,
Sakurai T, Tsukamoto N, Kudo-Saito C, Fujita T, Sumimoto H and
Kawakami Y: Immune suppression and resistance mediated by
constitutive activation of Wnt/β-catenin signaling in human
melanoma cells. J Immunol. 189:2110–2117. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yeh JR, Zhang X and Nagano MC: Indirect
effects of Wnt3a/β-catenin signalling support mouse spermatogonial
stem cells in vitro. PLoS One. 7:e400022012. View Article : Google Scholar
|
|
51
|
Shin H, Kwack MH, Shin SH, Oh JW, Kang BM,
Kim AA, Kim J, Kim MK, Kim JC and Sung YK: Identification of
transcriptional targets of Wnt/beta-catenin signaling in dermal
papilla cells of human scalp hair follicles: EP2 is a novel
transcriptional target of Wnt3a. J Dermatol Sci. 58:91–96. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Tamai K, Zeng X, Liu C, Zhang X, Harada Y,
Chang Z and He X: A mechanism for Wnt coreceptor activation. Mol
Cell. 13:149–156. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Capelluto DG, Kutateladze TG, Habas R,
Finkielstein CV, He X and Overduin M: The DIX domain targets
dishevelled to actin stress fibres and vesicular membranes. Nature.
419:726–729. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chen W, ten Berge D, Brown J, Ahn S, Hu
LA, Miller WE, Caron MG, Barak LS, Nusse R and Lefkowitz RJ:
Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated
endocytosis of Frizzled 4. Science. 301:1391–1394. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Pulvirenti T, Van Der Heijden M, Droms LA,
Huse JT, Tabar V and Hall A: Dishevelled 2 signaling promotes
self-renewal and tumorigenicity in human gliomas. Cancer Res.
71:7280–7290. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Mikels AJ and Nusse R: Purified Wnt5a
protein activates or inhibits beta-catenin-TCF signaling depending
on receptor context. PLoS Biol. 4:e1152006. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang J, Li Y, Wu Y, Yang T, Yang K, Wang
R, Yang J and Guo H: Wnt5a inhibits the proliferation and
melanogenesis of melanocytes. Int J Med Sci. 10:699–706. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wharton KA Jr, Zimmermann G, Rousset R and
Scott MP: Vertebrate proteins related to Drosophila naked cuticle
bind dishevelled and antagonize Wnt signaling. Dev Biol.
234:93–106. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zeng W, Wharton KA Jr, Mack JA, Wang K,
Gadbaw M, Suyama K, Klein PS and Scott MP: nakedcuticle encodes an
inducible antagonist of Wnt signalling. Nature. 403:789–795. 2000.
View Article : Google Scholar : PubMed/NCBI
|
